These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11161230)

  • 1. Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond.
    Rothenberg ML
    Oncologist; 2001; 6(1):66-80. PubMed ID: 11161230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CPT-11: new drug for metastatic colorectal cancer].
    Barone C; Pozzo C; Cassano A
    Tumori; 1999; 85(6):A1-11. PubMed ID: 10774581
    [No Abstract]   [Full Text] [Related]  

  • 3. Irinotecan and radiation in combined-modality therapy for solid tumors.
    Choy H; MacRae R
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Wiseman LR; Markham A
    Drugs; 1996 Oct; 52(4):606-23. PubMed ID: 8891470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan in the treatment of colorectal cancer: clinical overview.
    Vanhoefer U; Harstrick A; Achterrath W; Cao S; Seeber S; Rustum YM
    J Clin Oncol; 2001 Mar; 19(5):1501-18. PubMed ID: 11230497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standard therapy of CPT-11 for colorectal cancer].
    Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1345-51. PubMed ID: 11681240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the clinical experience with irinotecan (CPT-11).
    Horowitz RW; Wadler S; Wiernik PH
    Am J Ther; 1997; 4(5-6):203-10. PubMed ID: 10423612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase I inhibitors in the treatment of colorectal cancer.
    Rothenberg ML; Blanke CD
    Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan and cisplatin in upper gastrointestinal malignancies.
    Enzinger PC; Ilson DH; Saltz LB; O'Reilly EM; Kelsen DP
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):110-3. PubMed ID: 9726102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and clinical trials of topoisomerase inhibitors.
    Saijo N
    Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of irinotecan in patients with colorectal cancer.
    Rothenberg ML
    Semin Oncol; 1998 Oct; 25(5 Suppl 11):39-46. PubMed ID: 9786315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging world role of irinotecan in lung cancer.
    Langer CJ
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):15-21. PubMed ID: 11497227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPT-11: an original spectrum of clinical activity.
    Rothenberg ML
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):21-6. PubMed ID: 8633249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine/irinotecan combination regimens in colorectal cancer.
    Kerr DJ
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):27-9. PubMed ID: 12014865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan in the first-line treatment of colorectal cancer.
    Saltz LB
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):54-8. PubMed ID: 9726092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of intraperitoneal CPT-11.
    Matsui A; Okuda M; Tsujitsuka K; Enomoto K; Maruyama K
    Surg Oncol Clin N Am; 2003 Jul; 12(3):795-811, xv. PubMed ID: 14567032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan: a new antineoplastic agent for the management of colorectal cancer.
    Cersosimo RJ
    Ann Pharmacother; 1998 Dec; 32(12):1324-33. PubMed ID: 9876815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
    Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan: a new agent comes of age.
    Saltz LB
    Oncologist; 2001; 6(1):65. PubMed ID: 11161229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.